A BAC-based transgenic mouse specifically expresses an inducible Cre in the urothelium

Tian Huai Shen1, Nataliya Gladoun, Mireia Castillo-Martin

  • 1Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, New York, United States of America.

Plos One
|April 13, 2012
PubMed

Insights

We developed a new method for creating genetically modified mice with specific Cre expression in the urothelium. This bacterial artificial chromosome (BAC)-based recombineering approach improves tissue-specific gene targeting for research.

Area of Science:

  • Genetics
  • Developmental Biology
  • Molecular Biology

Background:

  • Cre-loxp recombination is crucial for studying gene function and disease models in mice.
  • Generating mice with specific Cre expression is essential but challenging with traditional methods.
  • The availability of reliable tissue-specific Cre driver lines is a key limitation.

Purpose of the Study:

  • To develop a more efficient and reliable method for generating tissue-specific Cre-expressing mice.
  • To create a novel bacterial artificial chromosome (BAC)-based system for inducible Cre expression in the urothelium.
  • To validate the specificity and efficacy of the new transgenic mouse model.

Main Methods:

  • Utilized bacterial artificial chromosome (BAC)-based recombineering to insert iCreERT2 cDNA into the Upk2 gene locus.
  • Generated BAC-transgenic mice carrying the modified Upk2 locus.
  • Crossed the generated mice with a Rosa26 reporter mouse line to assess Cre activity.
  • Confirmed urothelial-specific Cre expression via mRNA analysis and LacZ staining.

Main Results:

  • Successfully generated BAC-transgenic mice with inducible Cre recombinase expression.
  • Demonstrated highly specific Cre expression within the urothelium.
  • Reporter gene activation confirmed functional Cre activity in the target tissue.
  • The BAC-based recombineering approach proved efficient and reproducible.

Conclusions:

  • BAC-based recombineering offers a superior alternative to traditional cloning for generating tissue-specific Cre driver mice.
  • This method enables precise control over gene expression and deletion in specific cell types, like the urothelium.
  • The developed Upk2-iCreERT2 BAC transgenic line is a valuable tool for studying urothelial biology and disease.